A clinical trial of nifedipine in schizophrenia and tardive dyskinesia
- 31 July 1991
- journal article
- clinical trial
- Published by Elsevier in Pharmacology Biochemistry and Behavior
- Vol. 39 (3) , 743-745
- https://doi.org/10.1016/0091-3057(91)90157-w
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Nifedipine in the Treatment of Tardive DyskinesiaJournal of Clinical Psychopharmacology, 1990
- Effect of nifedipine and anticonvulsants of kainic acid-induced seizures in miceBrain Research, 1990
- DILTIAZEM FOR TARDIVE DYSKINESIA AND TARDIVE DYSTONIAThe Lancet, 1988
- The iminodipropionitrile (IDPN)-induced dyskinetic syndrome in mice: Antagonism by the calcium channel antagonist nifedipinePharmacology Biochemistry and Behavior, 1988
- Calcium channels and calcium channel antagonistsAnnals of Neurology, 1987
- An anti-tardive-dyskinesia effect of verapamilAmerican Journal of Psychiatry, 1986
- A negative, double-blind, placebo-controlled, clinical trial of verapamil in chronic schizophreniaBiological Psychiatry, 1986
- Nifedipine and flunarizine block amphetamine-induced behavioral stimulation in miceLife Sciences, 1986
- Differences between calcium channel inhibitors in their effects on phencyclidine-induced behavioral stimulation in micePharmacology Biochemistry and Behavior, 1985
- Antimanic effects of verapamilAmerican Journal of Psychiatry, 1984